SCHEMBL21313927

SCHEMBL21313927

O=C(c1ccc2[nH]nnc2c1)N1C=C2CN(C(=O)/C=C/c3ccc(-c4ccccc4)cn3)C[C@@H]2C1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HTR2B P41595 3/20 0.36
▸ MGLL Q99685 1/20 0.34
▸ KDM5A P29375 1/20 0.34
▸ ROCK2 O75116 2/20 0.33
▸ HPGD P15428 4/20 0.33
▸ NPC1 O15118 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ PDE10A Q9Y233 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ HSD11B1 P28845 1/20 0.31
▸ GHSR Q92847 1/20 0.31
▸ NAMPT P43490 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16963202 1.00 HTR2B (0.36) HTR2BMGLLKDM5AROCK2HPGD
SCHEMBL21313868 0.87 RAB9A (0.43) HPGDNPC1MAPTRAB9ASMN1; SMN2
SCHEMBL16963404 0.87 RAB9A (0.43) HPGDNPC1MAPTRAB9ASMN1; SMN2
SCHEMBL21313888 0.87 MKNK1 (0.38) HTR2BHPGDGHSRNAMPT
SCHEMBL16963192 0.87 GHSR (0.35) HTR2BHPGDNPC1MAPTRAB9A
SCHEMBL21313929 0.87 GHSR (0.35) HTR2BHPGDNPC1MAPTRAB9A
SCHEMBL16963356 0.87 MKNK1 (0.38) HTR2BHPGDGHSRNAMPT
SCHEMBL16963203 0.86 HTR2B (0.39) HTR2BMGLLHPGDGHSR
SCHEMBL16963201 0.86 HTR2B (0.39) HTR2BMGLLHPGDGHSR
SCHEMBL21313886 0.85 GPR183 (0.34) HPGDMEN1ALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900669-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback